Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria

被引：21
|
作者：
Endo, Takahiro [1 ,2 ]
Toyoshima, Shota [1 ,3 ]
Kanegae, Kazuko [1 ,3 ]
Izaki, Satoshi [1 ,2 ]
Nishimori, Nobuyuki [1 ,2 ]
Ito, Mana [1 ,2 ]
Sugai, Kazuko [4 ,5 ]
Hayama, Koremasa [1 ,2 ]
Terui, Tadashi [2 ]
Okayama, Yoshimichi [1 ,3 ]
机构：
[1] Nihon Univ, Sch Med, Res Inst Med Sci, Allergy & Immunol Res Project Team, Tokyo, Japan
[2] Nihon Univ, Sch Med, Dept Dermatol, Tokyo, Japan
[3] Nihon Univ, Sch Med, Ctr Inst Res & Med Educ, Tokyo, Japan
[4] Sugai Childrens Clin, Hiroshima, Japan
[5] Natl Inst Publ Hlth, Ctr Publ Hlth Informat, Saitama, Japan
来源：
ALLERGOLOGY INTERNATIONAL | 2019年 / 68卷 / 02期
关键词：
SERUM SKIN-TEST; AUTOLOGOUS SERUM; OMALIZUMAB;
D O I：
10.1016/j.alit.2018.09.006
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：270 / 273
页数：4
相关论文
共 50 条
  • [1] The Role Of Serum Biomarkers In Predicting Response To Omalizumab Therapy In Patients With Chronic Spontaneous Urticaria
    Cain, Wesley
    Ghosh, Debajyoti
    Bernstein, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB77 - AB77
  • [2] Identification of Biomarkers of chronic spontaneous Urticaria
    Smola, Anna
    Hawerkamp, Heike
    Kislat, Andreas
    Duschner, Nicole
    Olah, Peter
    Homey, Bernhard
    Meller, Stephan
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 3 - 3
  • [3] Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria
    Zubiaga-Fernandez, L.
    Testera-Montes, A.
    Rondon, C.
    Perez-Sanchez, N.
    Gomez-Perez, F.
    Vega-Chicote, J. M.
    Bartra, J.
    Ferrer, M.
    Eguiluz-Gracia, I.
    Torres, M. J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (06): : 402 - 411
  • [4] Biomarkers in patients with refractory chronic spontaneous urticaria
    Perez, I. L.
    Gomes, L. S.
    Pereira, G. F.
    Araujo, A. M.
    Mamede, L. Q.
    Souza, A. B.
    Motta, A. A.
    Kalil, J.
    Agondi, R. C.
    ALLERGY, 2020, 75 : 465 - 465
  • [5] Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria? Response
    Koski, Renee
    Kennedy, Katelin K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (03) : 342 - 342
  • [6] Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria
    Keskinkaya, Zeynep
    Kaya, Ozge
    Mermutlu, Selda Isik
    Ogretmen, Zerrin
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (08) : 786 - 793
  • [7] Chronic Idiopathic Urticaria Index (CIUI) As a Tool For Predicting Response To Cyclosporine In Pediatric Patients With Refractory Autoimmune Urticaria
    Breslin, Moira E.
    Geng, Bob
    Roberts, Robert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB119 - AB119
  • [8] Biomarkers of disease activity in patients with chronic spontaneous urticaria
    Plavsic, Aleksandra
    Tomic-Spiric, Vesna
    Arandjelovic, Snezana
    Miskovic, Rada
    Dimitrijevic, Milan
    Peric-Popadic, Aleksandra
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 1017 - 1022
  • [9] Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria
    Sanchez-Borges, M.
    Capriles-Hulett, A.
    Caballero-Fonseca, F.
    Gonzalez-Aveledo, L.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 50 (01) : 5 - 9
  • [10] Factors Predicting Success for Chronic Urticaria Patients Treated with Cyclosporine
    Hollander, S. M.
    Joo, S. S.
    Wedner, H. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB266 - AB266
12345